NATACYN (NATAMYCIN OPHTHALMIC SUSPENSION) 5%
Live / Allowed — Notice of allowance issued (as of 22 Apr 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98402032
- Mark type
- Slogan / phrase
- Filed
- 12 Feb 2024
- Published for opposition
- 25 Feb 2025
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for ophthalmological use containing natamycin; topical antifungal compositions for ophthalmological use containing natamycin
Owner
- Harrow IP, LLC, Nashville, TN, US
- Harrow IP, LLC, Nashville, TN, US
Prior registrations
Prosecution history
- 22 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Feb 2025 — PUBLISHED FOR OPPOSITION
- 19 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION WRITTEN